Sort by
Refine Your Search
-
Category
-
Employer
-
Field
-
directly to the AXA RF, they first have to submit a short proposal to the UZH Research & Grants Office. In case multiple candidates are interested to apply, the UZH Research & Grants Office has to pre-select
-
novel in vivo gene therapy approaches targeting hematopoietic stem cells. You will generate data on efficacy and safety of gene therapy vectors in multiple target cells and carry on preclinical
-
/apply/nccr-antiresist-fellowship-call-2025 Review of applications will start after 15 January 2026. Shortlisted candidates will be informed in early February 2026 about the following interview procedure
-
/apply/nccr-antiresist-fellowship-call-2025 Review of applications will start after 15 January 2026. Shortlisted candidates will be informed in early February 2026 about the following interview procedure
-
conduct their research at the Biozentrum at the moment. Our selection procedure Our selection procedure is based on in-person interactions on site. Shortlisted candidates will be invited to the Biozentrum
-
/apply/nccr-antiresist-fellowship-call-2025 Review of applications will start after 15 January 2026. Shortlisted candidates will be informed in early February 2026 about the following interview procedure
-
Digital Processes: Integrated information management from office to site, incl. visual analytics and LLM-enabled processes. Intelligent, Collaborative Project Delivery: Greater data transparency and multi
-
school in hand by June 2026. A PhD certificate or equivalent is required at least three months prior to the start of the fellowship to ensure that all paperwork can be processed in a timely manner